Treatment trajectories in urologic cancers
Longitudinal evaluation of urologic cancer treatment landscape, toxicity, and molecular testing: a decade of real-world evidence Principal Investigator : Dr. Alice DragomirInstitution: McGill University Health Centre (MUHC)Sponsor: PROVEM Scientific background Urologic cancers, including prostate, bladder, and kidney cancers, represent a substantial portion of the oncology burden in Canada. Over the past decade, their management has […]